Search Results for "Asmanex Twisthaler"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Asmanex Twisthaler. Results 1 to 10 of 10 total matches.
See also: mometasone, mometasone furoate
Mometasone (Asmanex Twisthaler) for Asthma
The Medical Letter on Drugs and Therapeutics • Dec 05, 2005 (Issue 1223)
Mometasone (Asmanex Twisthaler) for Asthma ...
The FDA has approved marketing of the corticosteroid mometasone furoate in an orally inhaled dry powder formulation (Asmanex Twisthaler - Schering-Plough) for maintenance treatment of asthma in patients at least 12 years old. Mometasone is also available as a mid-potency topical corticosteroid cream (Elocon) and as an intranasal spray (Nasonex) for treatment of allergic rhinitis.
Ciclesonide (Alvesco) - A New Inhaled Corticosteroid for Asthma
The Medical Letter on Drugs and Therapeutics • Sep 22, 2008 (Issue 1295)
Mometasone furoate
Asmanex Twisthaler DPI (30, 60, 120 inh/unit) 220-440 mcg 1x/day 4-11 yrs: 113.73 ...
The FDA has approved the marketing of the corticosteroid ciclesonide (Alvesco - Sepracor) in a hydrofluoroalkane (HFA) metered-dose inhaler formulation for maintenance treatment of asthma in patients >12 years old. Ciclesonide is also available in the US as a nasal spray for allergic rhinitis (Omnaris), and has been available for asthma in Europe since 2003.
Budesonide/Formoterol (Symbicort) for Asthma
The Medical Letter on Drugs and Therapeutics • Feb 11, 2008 (Issue 1279)
mcg bid 89.99
44, 110, 220 mcg/
inhalation
Mometasone furoate
Asmanex Twisthaler DPI (30, 60, 120 ...
A combination of the corticosteroid budesonide and the long-acting beta2-agonist formoterol (Symbicort - AstraZeneca) has become available in a metered dose inhaler for long-term maintenance treatment of asthma in patients ≥ 12 years old. A combination product that contains fluticasone propionate and salmeterol (Advair) is already available for this indication in the US. Neither one of these combinations is approved for acute treatment of asthma symptoms. A dry powder inhaler formulation of Symbicort has been available in Europe and Canada for several years.
Comparison Table: Inhaled Corticosteroids for Treatment of COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
N.A.
Mometasone furoate –
Asmanex HFA (Merck)
Asmanex Twisthaler (Merck)
50, 100, 200 mcg/inh
110 ...
View the Comparison Table: Inhaled Corticosteroids for Treatment of COPD
Table: Correct Use of Inhalers for COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
after using an inhaler containing a corticosteroid
Once- or twice-daily dosing
Asmanex Twisthaler ...
View the Table: Correct Use of Inhalers for COPD
Fluticasone Furoate (Arnuity Ellipta) for Asthma
The Medical Letter on Drugs and Therapeutics • May 25, 2015 (Issue 1469)
mcg bid 144.00
44, 110, 220 mcg/inh
Mometasone furoate –
Asmanex Twisthaler (Merck) DPI (30, 60 ...
The FDA has approved Arnuity Ellipta (GSK), a single-agent
inhaler containing the corticosteroid fluticasone
furoate, for once-daily maintenance treatment of
asthma in patients ≥12 years old. Fluticasone furoate
is also available in combination with the long-acting
beta2-agonist vilanterol as Breo Ellipta for treatment
of asthma and COPD.
Table: Some Inhaled Drugs for Treatment of Asthma (online only)
The Medical Letter on Drugs and Therapeutics • Dec 14, 2020 (Issue 1613)
Mometasone furoate –
Asmanex HFA (Merck) 50, 100, 200 mcg/inh HFA MDI (120 inh/unit) 200-400 mcg bid9
Low ...
View the table: Some Inhaled Drugs for Treatment of Asthma
Table: Correct Use of Inhalers for Asthma (online only)
The Medical Letter on Drugs and Therapeutics • Dec 14, 2020 (Issue 1613)
using an inhaler containing a
corticosteroid
Once- or twice-daily dosing
Asmanex Twisthaler ...
View the table: Correct Use of Inhalers for Asthma
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
(120 inh/unit) 200-400 mcg bid 224.90
Asmanex Twisthaler 110, 220 mcg/inh DPI (30, 60, 120 inh/unit ...
The main goals of treatment for chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
and prevent disease progression. Several guidelines
and review articles on COPD treatment have been
published in recent years. Treatment of acute
exacerbations is not discussed here.
Drugs for Asthma
The Medical Letter on Drugs and Therapeutics • Dec 14, 2020 (Issue 1613)
, 100, 200 mcg/inh Asmanex Twisthaler DPI (7, 30 inh/unit) 220-440 mcg once/day 4-11 yrs: 110 mcg once ...
The goal of asthma treatment is to control symptoms,
prevent exacerbations, and maintain normal lung
function. Management of acute exacerbations
of asthma in the emergency department is not
discussed here.